Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Clinical trial NCT06678620 · COMPLETED

Trial details

NCT number: NCT06678620
Sponsor: Reinovax Biologics Co., LTD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Infectious Disease

Start date: 2024-04-20
Primary completion: 2024-12-12
Enrollment: 992

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.